Goldman Sachs
KRMD icon

Goldman Sachs’s KORU Medical Systems KRMD Stock Holding History

Goldman Sachs’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$975K Buy
225,756
+56,407
+33% +$280K ﹤0.01% 5102
2025
Q4 		$984K Buy
169,349
+41,488
+32% +$199K ﹤0.01% 5154
2025
Q3 		$490K Buy
127,861
+37,136
+41% +$142K ﹤0.01% 5526
2025
Q2 		$325K Sell
90,725
-152,056
-63% -$432K ﹤0.01% 5392
2025
Q1 		$617K Buy
242,781
+158,914
+189% +$590K ﹤0.01% 5058
2024
Q4 		$323K Buy
+83,867
New +$272K ﹤0.01% 5466
2024
Q3 		– Sell
-404,929
Closed -$1.07M – 5971
2024
Q2 		$1.07M Buy
+404,929
New +$926K ﹤0.01% 4377
2021
Q4 		– Sell
-16,208
Closed -$46K – 6588
2021
Q3 		$46K Sell
16,208
-9,742
-38% -$32.2K ﹤0.01% 6061
2021
Q2 		$120K Sell
25,950
-12,330
-32% -$48.4K ﹤0.01% 5902
2021
Q1 		$135K Buy
38,280
+21,133
+123% +$91.5K ﹤0.01% 5764
2020
Q4 		$103K Sell
17,147
-21,601
-56% -$121K ﹤0.01% 5285
2020
Q3 		$280K Buy
+38,748
New +$344K ﹤0.01% 4769
2020
Q2 		– Sell
-139,679
Closed -$1.05M – 5362
2020
Q1 		$1.05M Buy
139,679
+129,629
+1,290% +$872K ﹤0.01% 3721
2019
Q4 		$66K Buy
+10,050
New +$49K ﹤0.01% 5095

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $109M AUM
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Goldman Sachs's KRMD Position: Q1 2026 in Review

Goldman Sachs increased its KORU Medical Systems (KRMD) stake by 33% in Q1 2026, buying an estimated $280K and bringing the position to 225,756 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #5102.

Goldman Sachs first reported a position in KRMD in Q4 2019 and has held it in 14 quarters since. The position peaked at $1.07M in Q2 2024. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Goldman Sachs held 225,756 shares of KORU Medical Systems worth $975K as of Q1 2026.
  • Goldman Sachs bought 56,407 KORU Medical Systems shares in Q1 2026, an estimated $280K.
  • KORU Medical Systems made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5102 holding.
  • Goldman Sachs first reported a position in KORU Medical Systems in Q4 2019 and has held it in 14 quarters since.
  • Goldman Sachs's KORU Medical Systems position peaked at $1.07M in Q2 2024.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.